The Cigna Group (FRA:CGN)
Germany
· Delayed Price · Currency is EUR | Market Cap | 75.36B |
| Revenue (ttm) | 236.27B |
| Net Income (ttm) | 4.66B |
| Shares Out | n/a |
| EPS (ttm) | 16.64 |
| PE Ratio | 16.18 |
| Forward PE | 10.82 |
| Dividend | 5.35 (1.97%) |
| Ex-Dividend Date | Jun 3, 2025 |
| Volume | n/a |
| Average Volume | 11 |
| Open | 271.85 |
| Previous Close | 271.55 |
| Day's Range | 271.85 - 271.85 |
| 52-Week Range | 251.55 - 331.30 |
| Beta | n/a |
| RSI | 57.39 |
| Earnings Date | Jul 31, 2025 |
About The Cigna Group
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company’s Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other product... [Read more]
Financial Performance
In 2024, The Cigna Group's revenue was $247.12 billion, an increase of 26.56% compared to the previous year's $195.27 billion. Earnings were $3.43 billion, a decrease of -33.50%.
Financial numbers in USD Financial StatementsNews
The Cigna Group's Second Quarter 2025 Earnings Release Details
BLOOMFIELD, Conn. , June 25, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) will release its second quarter 2025 financial results on Thursday, July 31, 2025, and will host a co...
Cigna sues Bristol Myers for alleged monopoly over blockbuster cancer drug
Cignaaccused BristolMyers Squibb of violating antitrust law by keeping generic versions of its blood cancerdrug Pomalyst off the market to retain a monopoly.
Cigna files antitrust case against Bristol Myers over Pomalyst sales
Cigna sues Bristol Myers over alleged monopoly for multiple myeloma drug Pomalyst
Cigna sued Bristol Myers on Tuesday, accusing the drugmaker of violating federal antitrust law by maintaining a monopoly over a blockbuster multiple myeloma drug sold under the brand name Pomalyst.
US health chief Kennedy met with insurers on prior authorization requirements
U.S. health secretary Robert F. Kennedy Jr. met with major health insurers on Monday, extracting pledges that they will take additional measures to simplify their requirements for prior approval on me...
Cigna: Valuation Discount To Historical And Sector Averages Persists
How Is The Market Feeling About Cigna Group?
Cigna Group's (NYSE: CI) short percent of float has fallen 14.19% since its last report. The company recently reported that it has 2.73 million shares sold short , which is 1.33% of all regular share...
Wake Up Wall Street - 2 Massively Mispriced Dividend Gems
I believe the odds favor long-term market gains. Analysts' optimism supports my view that overlooked areas offer the best opportunities now. That's why I'm focusing on two dividend stocks with rising ...
Cigna Healthcare Unveils Industry-Leading AI-Powered Digital Tools for a Simple and Reliable Customer Experience
New features blend innovation, responsible AI, and human interactions to better support customers in their health care journeys As new data show 4 out of 5 U.S. adults don't feel confident in their kn...
The Cigna Group Health Equity Impact Fund Opens 2025 Grants
The Fund will distribute another $3 million to nonprofits to improve health outcomes BLOOMFIELD, Conn. , June 4, 2025 /PRNewswire/ -- The Cigna Group Foundation today announced the second year of gran...
The Cigna Group Announces Appointment of Michael J. Hennigan to Board of Directors
BLOOMFIELD, Conn. , June 2, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced today that Michael J.
Here's How Much $100 Invested In Cigna Group 15 Years Ago Would Be Worth Today
Cigna Group (NYSE: CI) has outperformed the market over the past 15 years by 3.91% on an annualized basis producing an average annual return of 16.06%. Currently, Cigna Group has a market capitalizat...
5 stocks to watch on Friday: NTAP, PD, WFC, CVS and CI
CVS Health, Cigna sue Arkansas over law banning PBM-owned pharmacies
Cigna Adds Kerecis Intact Fish-Skin Grafts to Coverage Policy
ARLINGTON, Va. & REYKJAVIK, Iceland--(BUSINESS WIRE)-- #kerecis--Cigna Insurance Company now includes Kerecis products in its medical coverage policy for the treatment of diabetic foot ulcers.
Cigna’s Evernorth caps weight-loss drug copays at $200/month
Cigna to offer $200 Wegovy, Zepbound weight-loss benefit
Cigna said on Wednesday it was launching an add-on to pharmacy benefit management plans in which patients could pay no more than $200 a month out-of-pocket for weight-loss drugs Wegovy and Zepbound.
Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs
Cigna's pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.
Evernorth Launches New Benefit Option That Drives Lower Net Cost for Weight Loss Medicines and Limits Patient Cost to No More Than $200 Per Month
Patients can save as much as $3600 per year versus direct-to-consumer manufacturer programs, and out of pocket cost applies to their annual deductible New offering helps employers meet growing demand ...
Here's How Much You Would Have Made Owning Cigna Group Stock In The Last 20 Years
Cigna Group (NYSE: CI) has outperformed the market over the past 20 years by 3.82% on an annualized basis producing an average annual return of 12.12%. Currently, Cigna Group has a market capitalizat...
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion
After Donald Trump signed an executive order slashing drug prices last week, experts have highlighted how pharmacy benefit managers (PBMs) could be hit the hardest despite pharmaceutical companies fac...
Our Top 10 High-Growth Dividend Stocks -- May 2025
The article provides a methodology for selecting high-growth dividend-paying stocks, focusing on dividend growth and sustainability rather than high current yield. We use our proprietary models to rat...
Texas Rep. Julie Johnson Sold Up to $2.29M Worth of Amazon.com Stock
An official report on May 14, 2025 reveals Representative Julie Johnson's recent sale of Amazon.com (NASDAQ: AMZN) stock, valued between $223,139 and $2,295,000. The transaction took place on May 14,...
CVS Health, Cigna Stocks Dip Tuesday: What's Going On?
CVS Health Corporation (NYSE: CVS) and The Cigna Group (NYSE: CI) shares trading lower Tuesday. President Donald Trump on Monday signed an executive order aimed at reducing the cost of prescription ...
Cigna and CVS shares fall as Trump targets ‘middlemen' in sweeping executive order against Big Pharma
The market reaction came as Trump signed a wide-ranging executive order aimed at slashing prescription drug prices in the US.